Skip to content

Navan, Inc. NAVN Change in Deferred Revenue

Change in Deferred Revenue at other companies

MYR Group logo
MYR GroupMYRG
-$18.75M+46.3%
ALN
Alnylam PharmaceuticalsALNY
-$1.63M+94.0%
Federal Signal logo
Federal SignalFSS
-$2.18M-221%
Commvault Systems logo
Commvault SystemsCVLT
$52.94M+78.0%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$427K+48.2%
Materion logo
MaterionMTRN
-$1.96M+57.6%

Other financials

Income statement

See full
Revenue$220.2M+39.9%
Gross profit$163.1M+45.9%
Operating income-$18.1M-13.9%
Net income-$20.5M+66.5%
EPS (diluted)-$0.08+94.0%

Balance sheet

See full
Cash & equivalents$645.0M+70.1%
Total debt$172.5M
Total equity$1.2B+204%
Total assets$1.7B

Cash flow

See full
Operating cash flow-$6.8M-249%
CapEx$105.0K+16.7%
Free cash flow-$6.9M-255%

Valuation

See full
Market cap$5.57B
Enterprise value$5.1B
P/S7.3×

Profitability

See full
Gross margin72.1%
Operating margin-26%
Net margin-46.7%
FCF margin-41.5%

Returns & leverage

See full
Return on equity-1,572.6%
Debt / equity0.1×
Current ratio4.3×

Where this comes from

Reported directly by Navan, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Navan, Inc. ’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Navan, Inc. 's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Navan, Inc. 's change in deferred revenue?
Navan, Inc. (NAVN) reported change in deferred revenue of -$1.91M in Q1 2026.
How has Navan, Inc. 's change in deferred revenue changed year-over-year?
Navan, Inc. 's change in deferred revenue decreased by 156.9% year-over-year, from $3.36M to -$1.91M.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.